ADB-CHMINACA

ADB-CHMINACA

Shot Description:

ADB-CHMINACA CAS 1185887-13-1 ADB-CHMINACA (also known as MAB-CHMINACA) is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor with a binding affinity of Ki = 0.289 nM and was originally developed by Pfizer in 2009 as an analgesic medication. It was identified in cannabinoid blends in Japan in early 2015.

Inquiry Now

INQUIRY DETAILS *

INQUIRY DETAILS
  • captcha

Description:

ADB-CHMINACA CAS 1185887-13-1

ADB-CHMINACA

ADB-CHMINACA (also known as MAB-CHMINACA) is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB1 receptor with a binding affinity of Ki = 0.289 nM and was originally developed by Pfizer in 2009 as an analgesic medication. It was identified in cannabinoid blends in Japan in early 2015.

工厂5


Tags: